Trailing-twelve-month (TTM) revenue is $487.79 Million with a year-over-year growth of +39.47%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $117,691,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $136,959,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-16 |
| Q1 FY2026Period ended 2026-03-31 | $110,474,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $122,663,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $487,787,000 |
Current P/S: $672,106,559 market capitalization ÷ $487,787,000 TTM revenue = 1.38x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:15:23.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $122.66M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:16:53.341Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Commercial | $151M | $137M | N/A | N/A | N/A | N/A |
| Mobility | $104M | $135M | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| APAC | $47M | $35M | N/A | N/A | N/A | N/A |
| EMEA | $34M | $42M | N/A |
$487.79M
$487.79 Million
+39.47%
vs. $349.74M a year ago (TTM)
+22.33%
5 Year compound annual growth rate
1 Year
+39.47%
3 Year
+23.40%
5 Year
+22.33%
10 Year
+7.88%
15 Year
+3.63%
20 Year
+3.95%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $451.66M | +$146.21M | +47.87% |
| 2024 | $305.45M | +$39.36M | +14.79% |
| 2023 | $266.09M | +$26.25M | +10.94% |
| 2022 | $239.84M | +$24.87M | +11.57% |
| 2021 | $214.97M | +$48.84M | +29.39% |
| 2020 |
TTM Growth
+39.47%
3-Year CAGR
+23.40%
5-Year CAGR
+22.33%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:16:53.341Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Products | N/A | N/A | $149M | $174M | $192M | $328M |
|---|
| Services | $228M | $211M | $91M | $92M | $113M | $123M |
|---|
| N/A |
| N/A |
| ISRAEL | N/A | N/A | $3M | $4M | $15M | $9M |
|---|
| Latin America | $143M | $132M | N/A | N/A | N/A | N/A |
|---|
| North America | $55M | $74M | N/A | N/A | N/A | N/A |
|---|
| Other | N/A | N/A | $82M | N/A | N/A | N/A |
|---|
| Other Geographical Region | N/A | N/A | N/A | $105M | $92M | $97M |
|---|
| PERU | N/A | N/A | $58M | $53M | $52M | $70M |
|---|
| United States | N/A | N/A | $97M | $103M | $146M | $276M |
|---|
| $166.13M |
| ($97.36M) |
| (36.95%) |
| 2019 | $263.49M | ($2.90M) | (1.09%) |
| 2018 | $266.39M | ($16.36M) | (5.79%) |
| 2017 | $282.76M | +$3.21M | +1.15% |
| 2016 | $279.55M | +$82.01M | +41.51% |
